Files in this item
Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast
Item metadata
dc.contributor.author | Bellamy, C O | |
dc.contributor.author | Harrison, D J | |
dc.date.accessioned | 2015-03-16T13:01:01Z | |
dc.date.available | 2015-03-16T13:01:01Z | |
dc.date.issued | 1994-01 | |
dc.identifier | 173625326 | |
dc.identifier | 33292b59-1521-41e8-bb63-fb4255764c77 | |
dc.identifier | 0028039807 | |
dc.identifier.citation | Bellamy , C O & Harrison , D J 1994 , ' Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast ' , British Journal of Cancer , vol. 69 , no. 1 , pp. 183-185 . | en |
dc.identifier.issn | 0007-0920 | |
dc.identifier.other | RIS: urn:558959E4E274009601EEF1B0B28E33FE | |
dc.identifier.other | ORCID: /0000-0001-9041-9988/work/64034261 | |
dc.identifier.uri | https://hdl.handle.net/10023/6247 | |
dc.description.abstract | Glutathione S-transferase Pi (GST P) has been reported to be a marker of dysplastic lesions. For this reason expression of GST P by intraduct breast carcinoma was evaluated by immunohistochemistry. Thirty-seven of 92 carcinomas (40%) were GST P positive. GST P staining did not correlate with histological variables, c-erbB-2 overexpression or with clinical outcome. The GST P status of recurrences did not correlate with that of the index lesion. There is little evidence that GST P is a useful marker of the potential of intraduct breast carcinoma to become invasive. | |
dc.format.extent | 3 | |
dc.format.extent | 1212992 | |
dc.language.iso | eng | |
dc.relation.ispartof | British Journal of Cancer | en |
dc.rights | Copyright Macmillan Press Ltd., 1994. Full text is available as a scanned copy of the original print version from Europe PubMed Central PMC1968756 | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Breast neoplasms | en |
dc.subject | Carcinoma in situ | en |
dc.subject | Carcinoma, ductal, breast | en |
dc.subject | Evaluation studies as topic | en |
dc.subject | Female | en |
dc.subject | Follow-up studies | en |
dc.subject | Gene expression | en |
dc.subject | Glutathione Transferase | en |
dc.subject | Humans | en |
dc.subject | Immunohistochemistry | en |
dc.subject | Isoenzymes | en |
dc.subject | Middle aged | en |
dc.subject | Proto-oncogene proteins | en |
dc.subject | Receptor, epidermal growth factor | en |
dc.subject | Receptor, erbB-2 | en |
dc.subject | R Medicine | en |
dc.subject | RC0254 Neoplasms. Tumors. Oncology (including Cancer) | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject.lcc | R | en |
dc.subject.lcc | RC0254 | en |
dc.title | Evaluation of glutathione S-transferase Pi in non-invasive ductal carcinoma of breast | en |
dc.type | Journal article | en |
dc.contributor.institution | University of St Andrews.School of Medicine | en |
dc.description.status | Peer reviewed | en |
dc.identifier.url | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968756/ | en |
This item appears in the following Collection(s)
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.